Cargando…

The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers

PURPOSE: Currently, the FDA allows biowaivers for Class I (high solubility and high permeability) and Class III (high solubility and low permeability) compounds of the Biopharmaceutics Classification System (BCS). Scientific evidence should be provided to support biowaivers for BCS Class I and Class...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parr, Alan, Hidalgo, Ismael J., Bode, Chris, Brown, William, Yazdanian, Mehran, Gonzalez, Mario A., Sagawa, Kazuko, Miller, Kevin, Jiang, Wenlei, Stippler, Erika S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689772/ https://www.ncbi.nlm.nih.gov/pubmed/26286187 http://dx.doi.org/10.1007/s11095-015-1773-4

Ejemplares similares

Evaluation of Excipient Risk in BCS Class I and III Biowaivers
por: Metry, Melissa, et al.
Publicado: (2022)

Per-6-Thiolated Cyclodextrins: A Novel Type of Permeation Enhancing Excipients for BCS Class IV Drugs
por: Asim, Mulazim Hussain, et al.
Publicado: (2020)

Overview of the European Medicines Agency's Experience With Biowaivers in Centralized Applications
por: Lenić, Ines, et al.
Publicado: (2019)

BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide
por: Markovic, Milica, et al.
Publicado: (2020)

Interchangeability Evaluation of Multisource Ibuprofen Drug Products Using Biowaiver Procedure
por: Shohin, I. E., et al.
Publicado: (2011)

Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ribavirin
por: Goodarzi, Navid, et al.
Publicado: (2016)

Solubility, Permeability, and Dissolution Rate of Naftidrofuryl Oxalate Based on BCS Criteria
por: Kus-Slowinska, Marta, et al.
Publicado: (2020)

Soluplus(®) polymeric nanomicelles improve solubility of BCS-class II drugs
por: Pignatello, Rosario, et al.
Publicado: (2022)

A Physiologically Based Pharmacokinetic Model for Studying the Biowaiver Risk of Biopharmaceutics Classification System Class I Drugs With Rapid Elimination: Dexketoprofen Trometamol Case Study
por: Zhang, Xian, et al.
Publicado: (2022)

ICH Guideline for Biopharmaceutics Classification System-Based Biowaiver (M9): Toward Harmonization in Latin American Countries
por: Miranda, Claudia, et al.
Publicado: (2021)

BCS glossary of computing
por: Burdett, Arnold, et al.
Publicado: (2016)

BCS: 50 years
por: Cooper, Leon N, et al.
Publicado: (2011)

Combined use of phospholipid complexes and self-emulsifying microemulsions for improving the oral absorption of a BCS class IV compound, baicalin
por: Wu, Huiyi, et al.
Publicado: (2014)

Distinguishing between the Permeability Relationships with Absorption and Metabolism To Improve BCS and BDDCS Predictions in Early Drug Discovery
por: Larregieu, Caroline A., et al.
Publicado: (2014)

Biomimetic Artificial Membrane Permeability Assay over Franz Cell Apparatus Using BCS Model Drugs
por: de Souza Teixeira, Leonardo, et al.
Publicado: (2020)

Nano-hydroxyapatite improves intestinal absorption of acetazolamide (BCS Class IV drug)–but how?
por: Kaneko, Kenichi, et al.
Publicado: (2022)

BCS Glossary of Computing and ICT
por: Panel, BCS Education and Training Expert, et al.
Publicado: (2008)

Can BCS and BEC be synthetized?
por: Aguilera-Navarro, V C, et al.
Publicado: (1997)

BCS glossary of computing and ICT
por: BCS Learning and Development
Publicado: (2013)

Spin waves and the BCS model
por: Wehrl, A
Publicado: (1970)

Excipients
Publicado: (1878)

Self-emulsifying drug delivery systems: A versatile approach to enhance the oral delivery of BCS class III drug via hydrophobic ion pairing
por: Asad, Muhammad, et al.
Publicado: (2023)

iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification System
por: Hastedt, Jayne E., et al.
Publicado: (2022)

Respiratory chain complex III deficiency due to mutated BCS1L: a novel phenotype with encephalomyopathy, partially phenocopied in a Bcs1l mutant mouse model
por: Tegelberg, Saara, et al.
Publicado: (2017)

Effective Lagrangians for BCS superconductors at T=0
por: Aitchison, Ian J.R., et al.
Publicado: (1994)

Effective theories of BCS superconductors at T=0
por: Aitchison, Ian Johnston Rhind, et al.
Publicado: (1994)

The BCS Glossary: of ICT and Computing Terms
por: British Computer Society. London. Schools Expert Panel Glossary Working Party
Publicado: (2003)

The BCS Critical Temperature at High Density
por: Henheik, Joscha
Publicado: (2022)

The BCS Energy Gap at High Density
por: Henheik, Joscha, et al.
Publicado: (2022)

Glycerine as an Excipient
Publicado: (1885)

Lanolin as an Excipient
Publicado: (1907)

Study of the effect of active pharmaceutical ingredients of various classes of BCS on the parameters of thermosensitive systems based on poloxamers
por: Bakhrushina, E.O., et al.
Publicado: (2023)

Effect of the Similarity of Formulations and Excipients of Approved Generic Drug Products on In Vivo Bioequivalence for Putative Biopharmaceutics Classification System Class III Drugs
por: Ren, Ping, et al.
Publicado: (2023)

Validation of an Ex Vivo Permeation Method for the Intestinal Permeability of Different BCS Drugs and Its Correlation with Caco-2 In Vitro Experiments
por: B. Sánchez, Aroha, et al.
Publicado: (2019)

Mobile testing: an ASTQB-BCS foundation guide
por: Black, Rex
Publicado: (2018)

The BCS-BEC crossover and the unitary Fermi gas
por: Zwerger, Wilhelm
Publicado: (2012)

The mathematical structure of the BCS-model and related models
por: Thirring, Walter Eduard
Publicado: (1969)

Weaving of bacterial cellulose by the Bcs secretion systems
por: Abidi, Wiem, et al.
Publicado: (2021)

Bcs1, a novel target for fungicide
por: Zhan, Jingyu, et al.
Publicado: (2023)

A quantum engine in the BEC–BCS crossover
por: Koch, Jennifer, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pnmtut0s72ja5k9ok0osqavkhj